Litcius/Paper detail

Inhibition of IL-6 in the treatment of fibrous dysplasia of bone: The randomized double-blind placebo-controlled TOCIDYS trial

Roland Chapurlat, D. Gensburger, Cédric Trolliet, Stéphanie Rouanet, Nadia Mehsen-Cêtre, Philippe Orcel

2022Bone28 citationsDOI

Topics & Concepts

PlaceboMedicineTocilizumabBone remodelingClinical endpointInternal medicineBone painRandomized controlled trialGastroenterologyPlacebo-controlled studySurgeryDouble blindPathologyRheumatoid arthritisAlternative medicineBone Tumor Diagnosis and TreatmentsBone health and treatmentsOral and Maxillofacial Pathology
Inhibition of IL-6 in the treatment of fibrous dysplasia of bone: The randomized double-blind placebo-controlled TOCIDYS trial | Litcius